A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

ClinicalTrials.gov ID: NCT05836324

Public ClinicalTrials.gov record NCT05836324. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Open-Label, Multicenter Study of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Study identification

NCT ID: NCT05836324
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Incyte Corporation; Industry
Enrollment: 570 participants

Conditions and interventions

Conditions

Interventions

INCA33890 Drug
bevacizumab Drug
FOLFIRI Drug
FOLFOX Drug
Cetuximab Drug
ADG126 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 23, 2023
Primary completion: May 2, 2029
Completion: May 2, 2029
Last update posted: Jul 22, 2026

2023 – 2029

United States locations

U.S. sites: 11
U.S. states: 8
U.S. cities: 10

Facility	City	State	ZIP	Site status
The Angeles Clinic and Research Institute	Los Angeles	California	90025	Recruiting
Valkyrie Clinical Trials	Los Angeles	California	90067	Recruiting
Dana Farber Cancer Institute	Boston	Massachusetts	02215	Recruiting
Cancer and Hematology Centers of Western Michigan-Start Midwest	Grand Rapids	Michigan	49546	Recruiting
Hackensack University Medical Center	Hackensack	New Jersey	07601	Recruiting
Nyu Langone Health - Long Island Hospital	Mineola	New York	11501	Recruiting
Laura and Isaac Perlmutter Cancer Center	New York	New York	10016	Recruiting
University of Pennsylvania	Philadelphia	Pennsylvania	19104	Recruiting
Lifespan Cancer Research Institute	Providence	Rhode Island	02903	Recruiting
University of Texas Md Anderson Cancer Center	Houston	Texas	77030	Recruiting
South Texas Accelerated Research Therapeutics	San Antonio	Texas	78229	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05836324, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 22, 2026 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05836324 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →